Trials / Conditions / Cervical Adenosquamous Cell Carcinoma
Cervical Adenosquamous Cell Carcinoma
5 registered clinical trials studyying Cervical Adenosquamous Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer NCT03469531 | Zhujiang Hospital | Phase 2 |
| Completed | Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer NCT02164461 | Advaxis, Inc. | Phase 1 |
| Completed | Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Th NCT00416455 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be NCT00389974 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer NCT00262821 | National Cancer Institute (NCI) | Phase 3 |